2006;290:E11319
In the UK, NICE technology appraisal guidance (TA664) recommends Saxenda only be prescribed within specialist weight management services for adults who meet specific eligibility criteria, including having a BMI of at least 35 kg/m (or 32.5 kg/m for certain ethnic groups) with a weight-related comorbidity
9711, otherwise known as the Food and Drug Administration Act of 2009, the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising or sponsorship of health products without the proper authorization from FDA is prohibited
Not all pharmacies maintain the same quality standards, and purity varies
Senescence and cancer - role and therapeutic opportunities
51 SarchielliP.AlbertiA.BaldiA.CoppolaF.RossiC.PierguidiL.et al (2006)